Clinical Trial Update: A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating two different rabies vaccine post-exposure regimens in Chinese children has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Rabies vaccine (rabies vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Virus Diseases | Phase 4 | Status: WITHDRAWN